The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2025 | Reflections on BTOG 2025 and the future of lung cancer care
Neal Navani, MA, MRCP, MSc, PhD, from University College London, UK, reflects on BTOG 2025 as a fantastic event and acknowledges the contributions of Prof. Sanjay Popat, who is stepping down as chair. He commends Prof. Popat for his leadership in lung cancer care and expresses confidence in Dr Tom Newsome Davis as the incoming chair. Prof. Navani highlights the conference’s role in fostering collaboration and learning, mentioning a talk by Dr Pasi Jänne on EGFR-targeted therapies and discussions by Professors David Baldwin and Robert Rintoul on practical challenges in lung cancer care. He emphasizes the significance of NHS England’s newly published service specification, which could enhance advocacy efforts and improve lung cancer care metrics nationwide. This interview took place at the BTOG 2025 congress in Belfast, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are
protected by copyright laws and treaties around the world. All rights are
reserved.
